title: Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients.
authors.affiliation: Department of Hematology, Galilee Medical Center, Faculty of Medicine, Bar Ilan University, Nahariya, Israel.
authors.forename: C
authors.initials: C
authors.lastname: Suriu
authors.affiliation: Department of Hematology, Galilee Medical Center, Faculty of Medicine, Bar Ilan University, Nahariya, Israel.
authors.forename: L
authors.initials: L
authors.lastname: Akria
authors.affiliation: Department of Hematology, Galilee Medical Center, Nahariya, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Azoulay
authors.affiliation: Department of Hematology, Galilee Medical Center, Nahariya, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Shaoul
authors.affiliation: Galilee Medical Center, Bar Ilan University, Faculty of Medicine, Nahariya, Israel.
authors.forename: M
authors.initials: M
authors.lastname: Barhoum
authors.affiliation: Department of Hematology, Galilee Medical Center, Faculty of Medicine, Bar Ilan University, Nahariya, Israel. andrei.braester@naharia.health.gov.il.
authors.forename: A
authors.initials: A
authors.lastname: Braester
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D009101:Multiple Myeloma / Q000097:blood* / Q000175:diagnosis* / Q000401:mortality*; D015996:Survival Rate
chemical_list: D014408:Biomarkers, Tumor